AnalystsJonathan WollebenJonathan Wolleben's Stock Forecasts
AnalystsJonathan Wolleben
Sectors:
Industries:
Analyst Ranking
Top 15%
#688 out of 4560 analysts
Average Return
+6.38%
Win Rate
38%47 out of 124
Risk vs Reward
Poor
Good
Jonathan Wolleben's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Madrigal Pharmaceuticals IncMDGL | +365.01% | $64.44 | $299.65 | 2022-05-09 - 2023-05-09 | Buy |
Pharvaris NvPHVS | +206.28% | $8.12 | $24.87 | 2023-02-26 - 2024-02-26 | Buy |
Pharvaris NvPHVS | +198.29% | $8.75 | $26.10 | 2023-01-10 - 2024-01-10 | Buy |
Pharvaris NvPHVS | +194.90% | $8.62 | $25.42 | 2022-12-08 - 2023-12-08 | Buy |
Proqr Therapeutics NvPRQR | +188.44% | $0.79 | $2.27 | 2022-04-13 - 2023-04-13 | Buy |
Jonathan Wolleben Analyst Color
Get additional color on Jonathan Wolleben's coverage of popular stocks
Jonathan Wolleben's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Savara IncSVRA | 3 | Buy | $8.00 | +70.58% | Reiterates | 5 days ago |
Rallybio CorpRLYB | 11 | Buy | $8.00 | +359.77% | Reiterates | 5 days ago |
Ocular Therapeutix IncOCUL | 13 | Buy | $24.00 | +380.00% | Reiterates | 8 days ago |
Pharvaris NvPHVS | 9 | Buy | $50.00 | +134.85% | Maintains | 13 days ago |
Crinetics Pharmaceuticals IncCRNX | 9 | Buy | $80.00 | +80.91% | Reiterates | a month ago |
Larimar Therapeutics IncLRMR | 9 | Buy | $25.00 | +287.00% | Reiterates | a month ago |
Spruce Biosciences IncSPRB | 6 | Buy | $3.00 | +327.96% | Maintains | a month ago |
Mirum Pharmaceuticals IncMIRM | 6 | Buy | $72.00 | +194.84% | Maintains | a month ago |
Clearside Biomedical IncCLSD | 8 | Buy | $5.00 | +264.96% | Reiterates | a month ago |
Protagonist Therapeutics IncPTGX | 6 | Buy | $42.00 | +56.42% | Reiterates | a month ago |
Structure Therapeutics IncGPCR | 4 | Buy | $91.00 | +152.15% | Reiterates | 2 months ago |
Madrigal Pharmaceuticals IncMDGL | 6 | Buy | $347.00 | +58.90% | Reiterates | 2 months ago |
Sagimet Biosciences IncSGMT | 5 | Buy | $46.00 | +974.77% | Maintains | 3 months ago |
Allakos IncALLK | 4 | Buy | $3.00 | +185.71% | Maintains | 3 months ago |
Aura Biosciences IncAURA | 4 | Buy | $19.00 | +163.16% | Maintains | 5 months ago |
Dbv Technologies SaDBVT | 7 | Buy | $4.00 | +488.24% | Reiterates | 9 months ago |
Altimmune IncALT | 8 | Buy | $15.00 | +98.15% | Reiterates | 9 months ago |
Proqr Therapeutics NvPRQR | 4 | Buy | $6.00 | +197.03% | Reiterates | a year ago |
Warner Music Group CorpWMG | 1 | Buy | $24.00 | -25.33% | Maintains | a year ago |
Biocryst Pharmaceuticals IncBCRX | 2 | Buy | $16.00 | N/A | Reiterates | a year ago |
Strongbridge Biopharma PLCSBBP | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.